BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 28863068)

  • 21. The Stem Cell-associated Transcription Factor SOX2 as a Diagnostic Marker of High-grade Squamous Intraepithelial Lesion of the Uterine Cervix in Comparison With p16 and Ki-67.
    Wolsky RJ; Harbour LN; Mirza KM; Montag AG; Gwin K
    Appl Immunohistochem Mol Morphol; 2018 Jul; 26(6):403-410. PubMed ID: 27490766
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficiency of immunohistochemical p16 expression and HPV typing in cervical squamous intraepithelial lesion grading and review of the p16 literature.
    Yildiz IZ; Usubütün A; Firat P; Ayhan A; Küçükali T
    Pathol Res Pract; 2007; 203(6):445-9. PubMed ID: 17543474
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Reliability of the CINtec p16INK4a immunocytochemical test in screening cervical precancerous lesions].
    Jović M; Nenadić D; Magić Z; Zoltarevski L; Durdević-Vukomanović B; Tatomirović Z; Strelić N; Vojvodić D
    Vojnosanit Pregl; 2008 Mar; 65(3):211-9. PubMed ID: 18494269
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is p16(INK4A) expression more useful than human papillomavirus test to determine the outcome of atypical squamous cells of undetermined significance-categorized Pap smear? A comparative analysis using abnormal cervical smears with follow-up biopsies.
    Nieh S; Chen SF; Chu TY; Lai HC; Lin YS; Fu E; Gau CH
    Gynecol Oncol; 2005 Apr; 97(1):35-40. PubMed ID: 15790434
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HR-HPV E6/E7 mRNA In Situ Hybridization: Validation Against PCR, DNA In Situ Hybridization, and p16 Immunohistochemistry in 102 Samples of Cervical, Vulvar, Anal, and Head and Neck Neoplasia.
    Mills AM; Dirks DC; Poulter MD; Mills SE; Stoler MH
    Am J Surg Pathol; 2017 May; 41(5):607-615. PubMed ID: 28403015
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of Lower Anogenital Squamous Terminology Recommendations on the Use of p16 Immunohistochemistry and the Proportion of High-Grade Diagnoses in Cervical Biopsy Specimens.
    Thrall MJ
    Am J Clin Pathol; 2016 Apr; 145(4):524-30. PubMed ID: 27124943
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prospective evaluation of p16/Ki-67 dual-stained cytology for managing women with abnormal Papanicolaou cytology: PALMS study results.
    Bergeron C; Ikenberg H; Sideri M; Denton K; Bogers J; Schmidt D; Alameda F; Keller T; Rehm S; Ridder R;
    Cancer Cytopathol; 2015 Jun; 123(6):373-81. PubMed ID: 25891096
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p16 is superior to Stathmin-1 and HSP27 in identifying cervical dysplasia.
    Liou S; Nilforoushan N; Kang Y; Moatamed NA
    Diagn Pathol; 2021 Sep; 16(1):85. PubMed ID: 34544445
    [TBL] [Abstract][Full Text] [Related]  

  • 29. p16INK4A immunohistochemistry is superior to HPV in situ hybridization for the detection of high-risk HPV in atypical squamous metaplasia.
    Kong CS; Balzer BL; Troxell ML; Patterson BK; Longacre TA
    Am J Surg Pathol; 2007 Jan; 31(1):33-43. PubMed ID: 17197917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adjunct p16(INK4a) immunohistochemistry aids the detection of high-grade squamous intraepithelial lesions in endocervical curettage specimens.
    Shah AA; Jeffus SK; Zhao Z; Stoler MH; Stelow EB
    Am J Clin Pathol; 2014 Mar; 141(3):342-7. PubMed ID: 24515761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunochemical assessment of p16 and HPV L1 capsid protein in cervical squamous intraepithelial lesions.
    Balan R; Giuşcă S; Căruntu ID; Gheorghiţă V; Neacşu D; Amălinei C
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(4):1118-24. PubMed ID: 21495457
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell cycle and/or proliferation markers: what is the best method to discriminate cervical high-grade lesions?
    Lorenzato M; Caudroy S; Bronner C; Evrard G; Simon M; Durlach A; Birembaut P; Clavel C
    Hum Pathol; 2005 Oct; 36(10):1101-7. PubMed ID: 16226110
    [TBL] [Abstract][Full Text] [Related]  

  • 33. p16 and MIB1 improve the sensitivity and specificity of the diagnosis of high grade squamous intraepithelial lesions: methodological issues in a report of 447 biopsies with consensus diagnosis and HPV HCII testing.
    Van Niekerk D; Guillaud M; Matisic J; Benedet JL; Freeberg JA; Follen M; MacAulay C
    Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S233-40. PubMed ID: 17825885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The expression of p16 and galectin-3 in cervical intraepithelial neoplasia (CIN) and squamous cell carcinoma (SCC) uterine cervix.
    Kumar R; Mandal S; Arora P; Mala YM; Khurana N
    J Obstet Gynaecol; 2021 Jul; 41(5):785-790. PubMed ID: 33073644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thin HSIL of the Cervix: Detecting a Variant of High-grade Squamous Intraepithelial Lesions With a p16INK4a Antibody.
    Reich O; Regauer S
    Int J Gynecol Pathol; 2017 Jan; 36(1):71-75. PubMed ID: 27513079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liquid-based cytology--new possibilities in the diagnosis of cervical lesions.
    Juric D; Mahovlić V; Rajhvajn S; Ovanin-Rakić A; Skopljanac-Macina L; Barisić A; Projić IS; Babić D; Susa M; Corusić A; Oresković S
    Coll Antropol; 2010 Mar; 34(1):19-24. PubMed ID: 20432728
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationships of p16 Immunohistochemistry and Other Biomarkers With Diagnoses of Cervical Abnormalities: Implications for LAST Terminology.
    Castle PE; Adcock R; Cuzick J; Wentzensen N; Torrez-Martinez NE; Torres SM; Stoler MH; Ronnett BM; Joste NE; Darragh TM; Gravitt PE; Schiffman M; Hunt WC; Kinney WK; Wheeler CM; ;
    Arch Pathol Lab Med; 2020 Jun; 144(6):725-734. PubMed ID: 31718233
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Comparison of E6H4 and G175-405 p16-specific Monoclonal Antibodies in Oropharyngeal Squamous Cell Carcinoma.
    Ennis CM; Rohrbach MR; Schwalbe M; Mahajan A; Hartig GK
    Appl Immunohistochem Mol Morphol; 2020 Apr; 28(4):290-295. PubMed ID: 30664533
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The predictive value of p16(INK4a) and hybrid capture 2 human papillomavirus testing for high-grade cervical intraepithelial neoplasia.
    Guo M; Hu L; Baliga M; He Z; Hughson MD
    Am J Clin Pathol; 2004 Dec; 122(6):894-901. PubMed ID: 15539381
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p16(INK4a) as a complementary marker of high-grade intraepithelial lesions of the uterine cervix. I: Experience with squamous lesions in 189 consecutive cervical biopsies.
    Dray M; Russell P; Dalrymple C; Wallman N; Angus G; Leong A; Carter J; Cheerala B
    Pathology; 2005 Apr; 37(2):112-24. PubMed ID: 16028838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.